Paradigm Shifts in Nocturnal Glucose Control in Type 2 Diabetes

Context A better understanding of nocturnal regulation of glucose homeostasis will provide the framework for designing rational therapeutic strategies to improve the management of overnight glucose in patients with type 2 diabetes (T2D). Objective To establish the nocturnal pattern and regulation of glucose production (EGP) in humans and to determine whether the pattern is dysregulated in people with T2D. Design Subjects were infused with [3-3H] glucose overnight. Arterial blood samples were drawn for hormones and analytes to estimate EGP throughout the night. Deuterium-labeled water was provided to measure gluconeogenesis (GNG) using the hexamethylenetetramine method of Landau. Setting Mayo Clinic Clinical Research Trials Unit, Rochester, MN, USA. Participants and Interventions A total of 43 subjects [23 subjects with T2D and 20 nondiabetic (ND) subjects comparable for age and body mass index] were included in this study. Main Outcome(s) Measure(s) Glucose and EGP. Results Plasma glucose, C-peptide, and glucagon concentrations were higher throughout the night, whereas insulin concentrations were higher in subjects with T2D vs ND subjects at 1:00 and 4:00 am but similar at 7:00 am. EGP was higher in the subjects with T2D than in the ND subjects throughout the night (P < 0.001). Glycogenolysis (GGL) fell and GNG rose, resulting in significantly higher (P < 0.001) rates of GNG at 4:00 and 7:00 am and significantly (P < 0.001) higher rates of GGL at 1:00, 4:00, and 7:00 am in T2D as compared with ND. Conclusions These data imply that optimal therapies for T2D for nocturnal/fasting glucose control should target not only the absolute rates of EGP but also the contributing pathways of GGL and GNG sequentially.

[1]  C. Cobelli,et al.  Nocturnal Glucose Metabolism in Type 1 Diabetes: A Study Comparing Single Versus Dual Tracer Approaches. , 2015, Diabetes technology & therapeutics.

[2]  Claudio Cobelli,et al.  Diurnal Pattern of Insulin Action in Type 1 Diabetes , 2013, Diabetes.

[3]  J. Radziuk.  The Suprachiasmatic Nucleus, Circadian Clocks, and the Liver , 2013, Diabetes.

[4]  Claudio Cobelli,et al.  The Effect of Walking on Postprandial Glycemic Excursion in Patients With Type 1 Diabetes and Healthy People , 2012, Diabetes Care.

[5]  C. Cobelli,et al.  Diurnal Pattern to Insulin Secretion and Insulin Action in Healthy Individuals , 2012, Diabetes.

[6]  Joseph S. Takahashi,et al.  Circadian Integration of Metabolism and Energetics , 2010, Science.

[7]  J. Radziuk,et al.  Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour? , 2006, Diabetologia.

[8]  R. Rizza,et al.  Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. , 2005, Diabetes.

[9]  C. Cobelli,et al.  Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. , 2004, Diabetes.

[10]  J. Sheehan,et al.  Fasting hyperglycemia: etiology, diagnosis, and treatment. , 2004, Diabetes technology & therapeutics.

[11]  Y. Miyazaki,et al.  Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. , 2004, The Journal of clinical endocrinology and metabolism.

[12]  R. Rizza,et al.  Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes. , 2004, Diabetes.

[13]  R. Rizza,et al.  Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes. , 2004, American journal of physiology. Endocrinology and metabolism.

[14]  R. DeFronzo,et al.  Hepatic and peripheral insulin resistance: A common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitus , 1982, Diabetologia.

[15]  R. Rizza,et al.  Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans. , 2003, Diabetes.

[16]  K. Petersen,et al.  Mechanism by which metformin reduces glucose production in type 2 diabetes. , 2000, Diabetes.

[17]  E. Ferrannini,et al.  Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. , 2000, Diabetes.

[18]  M. Jensen,et al.  Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. , 2000, Diabetes.

[19]  A J Scheen,et al.  Roles of circadian rhythmicity and sleep in human glucose regulation. , 1997, Endocrine reviews.

[20]  D L Rothman,et al.  Contribution of net hepatic glycogenolysis to glucose production during the early postprandial period. , 1996, The American journal of physiology.

[21]  J. Wahren,et al.  Use of 2H2O for estimating rates of gluconeogenesis. Application to the fasted state. , 1995, The Journal of clinical investigation.

[22]  R. Shulman,et al.  Liver glycogen turnover in fed and fasted humans. , 1994, The American journal of physiology.

[23]  R. Shulman,et al.  Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. , 1992, The Journal of clinical investigation.

[24]  J. Radziuk.  Hepatic glycogen in humans. II. Gluconeogenetic formation after oral and intravenous glucose. , 1989, The American journal of physiology.

[25]  J. Radziuk.  Hepatic glycogen in humans. I. Direct formation after oral and intravenous glucose or after a 24-h fast. , 1989, The American journal of physiology.

[26]  R. DeFronzo,et al.  Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. , 1989, Metabolism: clinical and experimental.

[27]  G. Reaven,et al.  Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes. , 1988, The Journal of clinical investigation.

[28]  R. Rizza,et al.  Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. , 1986, The Journal of clinical investigation.

[29]  P. Brunetti,et al.  Demonstration of a Dawn Phenomenon in Normal Human Volunteers , 1984, Diabetes.

[30]  R. Steele,et al.  Measurement of size and turnover rate of body glucose pool by the isotope dilution method. , 1956, The American journal of physiology.